The chairman of a U.S. advisory panel that urged approval for Inamed Corp.'s silicone gel breast implants last month has made an unusual appeal to regulators to reject the company’s application.
The chairman of a U.S. advisory panel that urged approval for Inamed Corp.'s silicone gel breast implants last month has made an unusual appeal to regulators to reject the company’s application.
